BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7275667)

  • 21. Alterations of globin chain synthesis and of red cell membrane proteins in congenital dyserythropoietic anemia I and II.
    Alloisio N; Jaccoud P; Dorleac E; Morle L; Philippe N; Margueritte G; Bryon PA; Delaunay J
    Pediatr Res; 1982 Dec; 16(12):1016-21. PubMed ID: 6185913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of red cell proteins in hemoglobinopathy.
    Chakrabarti A; Bhattacharya D; Basu A; Basu S; Saha S; Halder S
    Proteomics Clin Appl; 2011 Feb; 5(1-2):98-108. PubMed ID: 21246741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of HbA(2) in patients with and without beta-thalassemia and in the presence of HbS, HbC, HbE, and HbD Punjab hemoglobin variants: comparison of two systems.
    Higgins TN; Khajuria A; Mack M
    Am J Clin Pathol; 2009 Mar; 131(3):357-62. PubMed ID: 19233839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The proportion of hybrid heterodimers in homozygous or doubly heterozygous beta chain variant hemoglobinopathies associated with alpha chain hemoglobin variants.
    Krauss JS
    Ann Clin Lab Sci; 2000 Oct; 30(4):391-4. PubMed ID: 11045763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of erythrocyte calpain and calpastatin activities in beta 0-thalassemia/Hb E disease.
    Macotpet G; Wilairat P; Fucharoen S; Wasi P
    Birth Defects Orig Artic Ser; 1987; 23(5A):257-61. PubMed ID: 2825832
    [No Abstract]   [Full Text] [Related]  

  • 26. Sickle cell disease caused by Hb S/Québec-CHORI: treatment with hydroxyurea and response.
    Tubman VN; Bennett CM; Luo HY; Chui DH; Heeney MM
    Pediatr Blood Cancer; 2007 Aug; 49(2):207-10. PubMed ID: 17551985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biphasic blood oxygen dissociation curves in hemoglobin S hemoglobinopathies. Sickle cell heterozygotes.
    Cameron BF
    Biochem Biophys Res Commun; 1971 May; 43(4):888-92. PubMed ID: 5105606
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction of sickle cell hemoglobin with erythrocyte membranes.
    Shaklai N; Sharma VS; Ranney HM
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):65-8. PubMed ID: 6941263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of intracellular hemoglobin precipitation, low MCHC, and iron overload on red blood cell membrane peroxidation in thalassemia.
    Rachmilewitz EA
    Birth Defects Orig Artic Ser; 1976; 12(8):123-33. PubMed ID: 795476
    [No Abstract]   [Full Text] [Related]  

  • 30. Nitric oxide-mediated heme oxidation and selective beta-globin nitrosation of hemoglobin from normal and sickle erythrocytes.
    Hrinczenko BW; Schechter AN; Wojtkowski TL; Pannell LK; Cashon RE; Alayash AI
    Biochem Biophys Res Commun; 2000 Sep; 275(3):962-7. PubMed ID: 10973828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of capillary electrophoresis for the determination of hemoglobin variants.
    Castagnola M; Messana I; Cassiano L; Rabino R; Rossetti DV; Giardina B
    Electrophoresis; 1995 Aug; 16(8):1492-8. PubMed ID: 8529620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemoglobin S/hemoglobin Osler: a case with 3 beta globin chains. DNA sequence (AAT) proves that Hb Osler is beta 145 Tyr-->Asn.
    Hutt PJ; Donaldson MH; Khatri J; Fairbanks VF; Hoyer JD; Thibodeau SN; Moxness MS; McMorrow LE; Green MM; Jones RT
    Am J Hematol; 1996 Aug; 52(4):305-9. PubMed ID: 8701949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered structure of spectrin in the two types of hemoglobin H disease.
    Lamchiagdhase P; Wilairat P; Bunyaratvej A; Fucharoen S; Sahaphong S
    Birth Defects Orig Artic Ser; 1987; 23(5A):163-8. PubMed ID: 3689895
    [No Abstract]   [Full Text] [Related]  

  • 34. The binding of phenothiazines to oxyhemoglobin A and S.
    Wind M; Berliner A; Stella AS; Guttman C
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):759-66. PubMed ID: 4144819
    [No Abstract]   [Full Text] [Related]  

  • 35. Intracellular loss of free alpha chains in beta thalassemia.
    Bank A; O'Donnell JV
    Nature; 1969 Apr; 222(5190):295-6. PubMed ID: 5778407
    [No Abstract]   [Full Text] [Related]  

  • 36. Interspecies hybrid HbS: complete neutralization of Val6(beta)-dependent polymerization of human beta-chain by pig alpha-chains.
    Rao MJ; Malavalli A; Manjula BN; Kumar R; Prabhakaran M; Sun DP; Ho NT; Ho C; Nagel RL; Acharya AS
    J Mol Biol; 2000 Jul; 300(5):1389-406. PubMed ID: 10903876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemoglobin C in transgenic mice: effect of HbC expression from founders to full mouse globin knockouts.
    Fabry ME; Romero JR; Suzuka SM; Gilman JG; Feeling-Taylor A; Odunusi E; Factor SM; Bouhassira EE; Lawrence C; Nagel RL
    Blood Cells Mol Dis; 2000 Aug; 26(4):331-47. PubMed ID: 11042035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of hemoglobin C with erythrocyte ghosts.
    Reiss GH; Ranney HM; Shaklai N
    J Clin Invest; 1982 Nov; 70(5):946-52. PubMed ID: 6752202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural characterization of hemoglobin variants using capillary electrophoresis and fast atom bombardment mass spectrometry.
    Ferranti P; Malorni A; Pucci P
    Methods Enzymol; 1994; 231():45-65. PubMed ID: 7518889
    [No Abstract]   [Full Text] [Related]  

  • 40. Hemoglobinopathies mimicking Hb S/beta-thalassemia: Hb S/S with alpha-thalassemia and Hb S/Volga.
    Luo HY; Heeney M; Wang WC; Eung SH; Ware RE; Steinberg MH; Chui DH
    Am J Hematol; 2006 May; 81(5):361-5. PubMed ID: 16628724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.